Dubai firm signs deal to manufacture medical equipment

Gulf Scientific Corporation (GSC), a leading Dubai-based provider of laboratory solutions in the fields of analytical, material and life sciences in the Gulf Cooperation Council (GCC), headquartered in Dubai - United Arab Emirates, with regional offices in Riyadh, Jeddah, Dammam, Kuwait, Doha and Manama is pleased to announce its new strategic partnership with DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand.

DNA Script offers the SYNTAX System, the first DNA printer powered by Enzymatic DNA Synthesis, which is designed for ease of use, productivity, convenience, control, and confidentiality. The SYNTAX platform, consisting of SYNTAX System, kits and software, enables automated nucleic acid synthesis.

DNA Script CEO and co-founder, Thomas Ybert said: “We are thrilled to be partnering with Gulf Scientific Corporation. This collaboration will be critical to follow through on our commercial expansion strategy and deliver a top-quality sale and support experience to researchers and industry players as we build out DNA Script’s global channel network.

As the only company to commercialize an in-house DNA manufacturing capability that utilizes the power of EDS, we are committed to developing fast, reliable, best-in-class service and support to meet research needs in the region.”

Gulf Scientific Corporation Managing Director, Manaf Afyouni said: “As we continue pursuing our strategy to provide the scientific community with unique and innovative technologies, and following the significant genomic research growth and increased demand in the GCC, we are honored to build a strategic partnership with DNA Script and enable physicians, researchers, and industry experts across the GCC, to access a new technology that has a potential to revolutionize life sciences research by enabling custom DNA printed on demand.